2026 Guide: Key Medical Nonwoven Standards & Compliance

The medical industry demands the highest standards of safety, hygiene, and performance. As a key material for surgical gowns, drapes, and wound care, Spunlace Nonwoven fabrics must comply with rigorous international standards. Here is an overview of the critical standards and trends for 2026.

1. Key International Standards

To export medical nonwovens to global markets, manufacturers must ensure compliance with:

EN 13795 (Europe): This is the standard for surgical drapes and gowns. It categorizes products into "Standard Performance" and "High Performance" based on barrier properties against liquids and microbes.

AAMI PB70 (USA): The FDA recognizes this standard for liquid barrier performance.

Level 1-2: Minimal risk (e.g., isolation gowns).

Level 3-4: Moderate to high risk (requires high hydrostatic pressure resistance).

ISO 10993 (Biocompatibility): Crucial for any material touching patient skin. It tests for cytotoxicity, sensitization, and irritation.

2. The Shift Toward "Low Linting"

One of the most critical requirements in 2026 operating rooms is Low Linting. Loose fibers (lint) can carry bacteria into open wounds.

Spunlace Advantage: High-quality Spunlace nonwovens (especially woodpulp/polyester composites) offer superior low-linting properties compared to traditional cotton, making them ideal for surgical sponges and operating room towels.

3. Sustainability in Medical Disposables

A major trend for 2026 is the push for Biodegradable Medical Textiles. Hospitals are looking to reduce the carbon footprint of disposable PPE.

Solution: We are seeing a shift away from 100% synthetic binders. Bio-based Viscose and Lyocell nonwovens are increasingly being used for patient wipes and general cleaning in medical facilities to meet green procurement targets.

4. Jianghua’s Commitment

At Jianghua New Materials, our medical-grade nonwovens are produced in strict control environments. We provide comprehensive testing reports covering absorbency, strength, and microbial cleanliness to support our clients' regulatory filings in the EU and US markets.